Sakano Shigeru, Matsuyama Hideyasu, Kamiryo Yoriaki, Hayashida Shigeaki, Yamamoto Norio, Kaneda Yoshitaka, Nasu Takahito, Baba Yoshikazu, Shimabukuro Tomoyuki, Suga Akinobu, Yamamoto Mitsutaka, Aoki Akihiko, Takai Kimio, Yoshihiro Satoru, Oba Kazuo
Department of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan,
Int J Clin Oncol. 2015 Apr;20(2):362-8. doi: 10.1007/s10147-014-0721-3. Epub 2014 Jun 27.
Patients with urinary bladder urothelial carcinoma (UC) with variant histology have features of more advanced disease and a likelihood of poorer survival than those with pure UC. We investigated the impact of variant histology on disease aggressiveness and clinical outcome after radical nephroureterectomy (RNU) in Japanese patients with upper tract UC (UTUC). Information on variant histology might guide appropriate patient selection for adjuvant therapy after RNU.
We enrolled 502 UTUC patients treated with RNU in this retrospective cohort study, and analyzed associations of variant histology with clinicopathological variables and disease-specific survival.
The median follow-up was 41.4 months. A total of 60 (12.0 %) UTUC patients had variant histology. UTUC with variant histology was significantly associated with advanced pathological T stage (pT ≥ 3), higher tumor grade (G3), and more lymphovascular invasion (P < 0.0001). Variant histology in all patients was significantly associated with worse disease-specific survival after RNU on univariate analysis (P = 0.0004), but this effect did not remain significant on multivariate analysis. However, variant histology was a significantly independent predictor for disease-specific survival in patients with pT ≥ 3 tumors (P = 0.0095).
UTUC with variant histology might be a phenotype of high-grade, locally aggressive advanced tumors rather than of systemic disease. Variant histology may be useful for selection of patients with pT ≥ 3 UTUC for adjuvant therapy. Prospective studies in a larger number of patients with a centralized pathological review are needed to confirm our results.
具有变异组织学特征的膀胱尿路上皮癌(UC)患者具有疾病进展更严重的特征,且与纯UC患者相比,其生存可能性更低。我们调查了变异组织学对日本上尿路UC(UTUC)患者根治性肾输尿管切除术(RNU)后疾病侵袭性和临床结局的影响。变异组织学信息可能有助于指导RNU术后辅助治疗的合适患者选择。
在这项回顾性队列研究中,我们纳入了502例接受RNU治疗的UTUC患者,并分析了变异组织学与临床病理变量及疾病特异性生存的相关性。
中位随访时间为41.4个月。共有60例(12.0%)UTUC患者具有变异组织学特征。具有变异组织学特征的UTUC与晚期病理T分期(pT≥3)、更高的肿瘤分级(G3)以及更多的淋巴管侵犯显著相关(P<0.0001)。单因素分析显示,所有患者的变异组织学与RNU术后更差的疾病特异性生存显著相关(P = 0.0004),但在多因素分析中这种影响不再显著。然而,对于pT≥3肿瘤患者,变异组织学是疾病特异性生存的显著独立预测因素(P = 0.0095)。
具有变异组织学特征的UTUC可能是高级别、局部侵袭性晚期肿瘤而非全身性疾病的一种表型。变异组织学可能有助于选择pT≥3的UTUC患者进行辅助治疗。需要对更多患者进行前瞻性研究并进行集中病理评估以证实我们的结果。